Protagonist Therapeutics (PTGX) Earnings Date & Reports

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PTGX is expected to report earnings to fall 103.24% to -6 cents per share on April 30

Protagonist Therapeutics PTGX Stock Earnings Reports

Q1'25

Est.

$-0.06

Q4'24

Beat

by $1.79

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.10

Q1'24

Beat

by $2.07

The last earnings report on February 21 showed earnings per share of $1.98, beating the estimate of 19 cents. With 501.93K shares outstanding, the current market capitalization sits at 2.88B.

View a ticker or compare two or three

Compare

PTGX